Stock Events

Pacira BioSciences 

€18
20
+€0+0% Monday 13:57

Statistics

Day High
18
Day Low
17.8
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
828.52M
P/E Ratio
12.81
Dividend Yield
-
Dividend
-

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.53
0.65
0.77
0.89
Expected EPS
0.62
Actual EPS
0.62

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 82P.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
Mr. Charles A. Reinhart III, CPA, M.B.A.
Employees
711
Country
US
ISIN
US6951271005
WKN
000A1H68T

Listings